Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.54 |
| ▸ | MAOA | P21397 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | CALML3 | P27482 | 1/20 | 0.54 |
| ▸ | SDHA | P31040 | 1/20 | 0.54 |
| ▸ | F10 | P00742 | 8/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13428666 | 0.88 | MAOA (0.67) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL13428581 | 0.85 | F10 (0.62) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL13428653 | 0.83 | CALML3 (0.56) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL11982904 | 0.83 | MAOB (0.54) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL7710101 | 0.82 | MAOB (0.61) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL7710097 | 0.82 | MAOB (0.61) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL13428278 | 0.81 | F10 (0.51) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL13159169 | 0.81 | MAOB (0.66) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL10152699 | 0.80 | MAOB (0.65) | MAOBMAOALMNAPTGS1CALML3 | |
| SCHEMBL7710010 | 0.80 | MAOB (0.61) | MAOBMAOALMNAPTGS1CALML3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010036000-A2 | NOVEL OXAZOLIDINONE DERIVATIVES WITH CYCLIC AMIDOXIME OR CYCLIC AMIDRAZONE AND PHARMACEUTICAL COMPOSITIONS THEREOF | LEGOCHEM BIOSCIENCE LTD. (KR) | 2010-04-01 | — | — | WO | disclosed |